NEW YORK, June 28 (GenomeWeb News) - Interleukin Genetics has licensed the rights to variations in a gene associated with overweight from Tufts University, the company said today.

 

Interleukin, based in Waltham, Mass., obtained exclusive rights to develop and commercialize tests and nutritional products based on variations in the perilipin gene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.